The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Abstract
Chagas disease is caused by a parasite, Trypanosoma cruzi, transmitted primarily by a triatomine insect and affects approximately 8 million people in Latin American countries. The principal aim of the management of the disease is to avoid the development of cardiomyopathy and transmission by blood transfusion, congenital and organ transplants. Currently, benznidazole is the only etiological treatment commercially available for the disease until new and better drugs can be developed and tested. Benznidazole has been used even though it does not have all the conditions of an ideal drug. The efficacy and tolerance of benznidazole is inversely related to the age of the patient, while its side effects are more frequent in elderly patients. The side effects are systematically evaluated only in controlled studies designed for that purpose. However, the true clinical impact of the side effects could be different, considering that the treatment is for a short duration (between 30 and 60 days) and only carried out once. In this article, we discuss the benefits and risks of the treatment with benznidazole from a clinical point of view to be considered for the management of the treatment of chronic adult Chagas disease patients in the current medical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
(2016) · Lung Transplantation · doi:10.3109/9781439802571-25 · Cited by 2,157
ORGANIZACIÓN PANAMERICANA DE LA SALUD
Mujer, P., Desarrollo, S. Y., Costa, F. E., Rica, Carcedo, A. J. P., Sagot, M., de investigación, A., González, C., & Kilfoil, V. (2003) · Cited by 1,881
A Critical Review on Chagas Disease Chemotherapy
Coura, J. R., & Castro, S. L. D. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000100001 · Cited by 1,003
Pathogenesis of Chronic Chagas Heart Disease
Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., & Simões, M. V. (2007) · Circulation · doi:10.1161/circulationaha.106.624296 · Cited by 849
Evaluation and Treatment of Chagas Disease in the United States: A Systematic Review
Bern, C., Montgomery, S. P., Herwaldt, B. L., Rassi, A., Marin-Neto, J. A., Dantas, R. O., Maguire, J. H., Acquatella, H., Morillo, C., Kirchhoff, L. V., et al. (2007) · JAMA · doi:10.1001/jama.298.18.2171 · Cited by 775
Viotti, R., Vigliano, C., Lococo, B., Bertocchi, G., Petti, M., Alvarez, M. G., Postan, M., & Armenti, A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00006 · Cited by 598
Self-citationMaya, J. D., Cassels, B. K., Iturriaga-Vásquez, P., Ferreira, J., Faúndez, M., Galanti, N., Ferreira, A., & Morello, A. (2007) · Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2006.03.004 · Cited by 359
Jr, A. R., Rassi, A., & Little, W. C. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231205 · Cited by 317
Chagas disease and the US blood supply
Bern, C., Montgomery, S. P., Katz, L. M., et al. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32830ef5b6 · Cited by 146
Gascón, J., Albajar-Viñas, P., Cañas, E., Flores-Chavez, M. D., Prat, J. G. I., Herrera, R. N., Lafuente, C. A., Luciardi, H. L., Moncayo, Á., Balaguer, L. M., et al. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60153-4 · Cited by 106
Gascón, J., Albajar-Viñas, P., Cañas, E., Flores-Chavez, M. D., Prat, J. G. I., Herrera, R. N., Lafuente, C. A., Luciardi, H. L., Moncayo, Á., Balaguer, L. M., et al. (2007) · Revista Española de Cardiología · doi:10.1157/13100280 · Cited by 105
Etiological treatment of chronic Chagas disease: neglected ‘evidence’ by evidence-based medicine
Viotti, R. J., & Vigliano, C. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.717 · Cited by 71
Self-citationIndicadores clínicos de progresión de la miocarditis chagásica crónica
Viotti, R. J., Vigliano, C., Lococo, B., Petti, M. A., Bertocchi, G. L., Alvarez, M., & Armenti, A. (2005) · Revista Española de Cardiología · doi:10.1157/13078551 · Cited by 66
Self-citationClinical Predictors of Chronic Chagasic Myocarditis Progression
Viotti, R. J., Vigliano, C., Lococo, B., Petti, M. A., Bertocchi, G. L., Alvarez, M., & Armenti, A. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60436-2 · Cited by 49
Self-citationGruchalla, R. S. (1998) · PubMed · Cited by 35
Cited by
Rassi, A., Rassi, A., & Marin-Neto, J. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60061-x · Cited by 2,119
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
Khare, S., Nagle, A. S., Biggart, A., Lai, Y. H., Liang, F., Davis, L. C., Barnes, S. W., Mathison, C. J. N., Myburgh, E., Gao, M.-Y., et al. (2016) · Nature · doi:10.1038/nature19339 · Cited by 407
Dorny, P., Praet, N., Deckers, N., & Gabriel, S. (2009) · Veterinary Parasitology · doi:10.1016/j.vetpar.2009.05.026 · Cited by 380
Diagnosis and management of Chagas disease and cardiomyopathy
Ribeiro, A. L., Nunes, M. P., Teixeira, M. M., & Rocha, M. O. C. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.109 · Cited by 329
Chagas Disease Drug Discovery: Toward a New Era
Chatelain, E. (2015) · SLAS Discovery · doi:10.1177/1087057114550585 · Cited by 312
Metadata
- Authors
- Viotti, R., Vigliano, C., Lococo, B., Alvarez, M. G., Petti, M., Bertocchi, G., & Armenti, A.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2009-03
- Volume
- 7
- Issue
- 2
- Pages
- 157-163
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W2148446876
- Cited by
- 327
- References
- 16
- FWCI
- 15.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.